{"status":"ok","message-type":"event-list","message":{"next-cursor":"ea8724ae-e0a8-4439-8f4f-e7cc2d12d5d3","total-results":17,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T02:56:32Z","subj_id":"twitter:\/\/status?id=1091893168813965312","id":"5c076020-6f03-4f56-a17b-7c4221f3bb82","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-6af18b07-ea83-40ec-87dc-e29c0eea2e5b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091893168813965312","url":"twitter:\/\/status?id=1091893168813965312","title":"Tweet 1091893168813965312","issued":"2019-02-03T02:56:32.000Z","author":{"url":"twitter:\/\/user?screen_name=afcp_01"},"original-tweet-url":"twitter:\/\/status?id=1091893168813965312","original-tweet-author":null,"alternative-id":"1091893168813965312"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T02:59:22Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T02:57:52Z","subj_id":"twitter:\/\/status?id=1091893503288733696","id":"346d691d-7296-4e96-8fce-467d5cb56e85","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-37ae3d5b-3359-4466-852c-2799f0621c4d","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091893503288733696","url":"twitter:\/\/status?id=1091893503288733696","title":"Tweet 1091893503288733696","issued":"2019-02-03T02:57:52.000Z","author":{"url":"twitter:\/\/user?screen_name=ushi_mo"},"original-tweet-url":"twitter:\/\/status?id=1091893168813965312","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091893503288733696"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T03:00:30Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T02:58:21Z","subj_id":"twitter:\/\/status?id=1091893626634825728","id":"eb3db959-d9b9-4f81-9aa7-3cd0ea39781f","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-f2029584-0c78-4f06-aa06-5634c14c0606","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091893626634825728","url":"twitter:\/\/status?id=1091893626634825728","title":"Tweet 1091893626634825728","issued":"2019-02-03T02:58:21.000Z","author":{"url":"twitter:\/\/user?screen_name=koiseyo0422"},"original-tweet-url":"twitter:\/\/status?id=1091893168813965312","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091893626634825728"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T03:00:31Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T03:34:20Z","subj_id":"twitter:\/\/status?id=1091902679570214913","id":"3af115d2-af25-43a9-84a1-2d6e23865d72","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-38ed878b-ad09-4a6b-9c3a-3367c56c288b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091902679570214913","url":"twitter:\/\/status?id=1091902679570214913","title":"Tweet 1091902679570214913","issued":"2019-02-03T03:34:20.000Z","author":{"url":"twitter:\/\/user?screen_name=kankan551"},"original-tweet-url":"twitter:\/\/status?id=385183661194108928","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091902679570214913"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T03:36:49Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T07:20:30Z","subj_id":"twitter:\/\/status?id=1091959599987478530","id":"b29d629d-0db4-4454-9a9e-4cf829567b19","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-b3d19aee-2111-4a4f-8318-a05e0768ce93","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091959599987478530","url":"twitter:\/\/status?id=1091959599987478530","title":"Tweet 1091959599987478530","issued":"2019-02-03T07:20:30.000Z","author":{"url":"twitter:\/\/user?screen_name=yamayama_nae"},"original-tweet-url":"twitter:\/\/status?id=1091893168813965312","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091959599987478530"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T07:22:18Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T07:48:48Z","subj_id":"twitter:\/\/status?id=1091966721613692929","id":"d2519cdf-38a4-4bfe-9952-c50bf4f26b2d","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-cb94f01f-b15f-44a1-86bc-f480dbed7287","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091966721613692929","url":"twitter:\/\/status?id=1091966721613692929","title":"Tweet 1091966721613692929","issued":"2019-02-03T07:48:48.000Z","author":{"url":"twitter:\/\/user?screen_name=king1234stone"},"original-tweet-url":"twitter:\/\/status?id=1091893168813965312","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091966721613692929"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T07:53:43Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T07:53:37Z","subj_id":"twitter:\/\/status?id=1091967930311430144","id":"f8ab5916-3f8c-40f9-82f1-8d41f4e5a41a","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-a8ed57c5-c5b0-40d9-8700-fe1b9c178e63","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091967930311430144","url":"twitter:\/\/status?id=1091967930311430144","title":"Tweet 1091967930311430144","issued":"2019-02-03T07:53:37.000Z","author":{"url":"twitter:\/\/user?screen_name=cankan10887"},"original-tweet-url":"twitter:\/\/status?id=385183661194108928","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091967930311430144"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T07:56:21Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T07:53:30Z","subj_id":"twitter:\/\/status?id=1091967903895711745","id":"def3d489-4858-478e-a2ec-2b7491b3d8dc","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-a8ed57c5-c5b0-40d9-8700-fe1b9c178e63","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091967903895711745","url":"twitter:\/\/status?id=1091967903895711745","title":"Tweet 1091967903895711745","issued":"2019-02-03T07:53:30.000Z","author":{"url":"twitter:\/\/user?screen_name=cankan10887"},"original-tweet-url":"twitter:\/\/status?id=805587244757106688","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091967903895711745"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T07:56:21Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-03T07:53:53Z","subj_id":"twitter:\/\/status?id=1091968000624713728","id":"f2dd902a-32de-4295-9ed4-61140cc92fa0","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190203-twitter-365f8251-a1a0-41de-86bb-abfd1e19b6cb","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1091968000624713728","url":"twitter:\/\/status?id=1091968000624713728","title":"Tweet 1091968000624713728","issued":"2019-02-03T07:53:53.000Z","author":{"url":"twitter:\/\/user?screen_name=cankan10887"},"original-tweet-url":"twitter:\/\/status?id=1091893168813965312","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1091968000624713728"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-03T07:59:49Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-04T04:51:57Z","subj_id":"twitter:\/\/status?id=1092284603660787712","id":"27c21c67-6233-4001-83fd-6c534c515265","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190204-twitter-eeb059b0-6b2c-4aac-9ad0-e18992fd0d59","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1092284603660787712","url":"twitter:\/\/status?id=1092284603660787712","title":"Tweet 1092284603660787712","issued":"2019-02-04T04:51:57.000Z","author":{"url":"twitter:\/\/user?screen_name=mogurabus77"},"original-tweet-url":"twitter:\/\/status?id=385183661194108928","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1092284603660787712"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-04T04:54:49Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2019-02-07T03:05:27Z","subj_id":"twitter:\/\/status?id=1093344964166135808","id":"3dc6f29a-189f-4ac3-8551-c0dcb2c46b15","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20190207-twitter-a54a04c4-dfcb-4ad4-8f4b-59971d9b554b","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1093344964166135808","url":"twitter:\/\/status?id=1093344964166135808","title":"Tweet 1093344964166135808","issued":"2019-02-07T03:05:27.000Z","author":{"url":"twitter:\/\/user?screen_name=sofvot"},"original-tweet-url":"twitter:\/\/status?id=385183661194108928","original-tweet-author":"twitter:\/\/user?screen_name=afcp_01","alternative-id":"1093344964166135808"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/journals\/the-british-journal-of-psychiatry\/article\/reducing-antipsychotic-medication-in-people-with-a-learning-disability\/18ACB3976EFE748947527F99DFD35846","method":"landing-page-meta-tag","verification":"unrecognised-domain"},"timestamp":"2019-02-07T03:06:18Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2020-05-16T05:21:15Z","subj_id":"twitter:\/\/status?id=1261527110536978432","id":"b27651f5-3f60-4abf-9411-fae0292c9637","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20200516-twitter-34aef3a0-5c02-4c7a-bf73-2f530f3db59c","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1261527110536978432","url":"twitter:\/\/status?id=1261527110536978432","title":"Tweet 1261527110536978432","issued":"2020-05-16T05:21:15.000Z","author":{"url":"twitter:\/\/user?screen_name=cheke_hazuki"},"original-tweet-url":"twitter:\/\/status?id=1261483383206510593","original-tweet-author":"twitter:\/\/user?screen_name=kenichi_ohkubo","alternative-id":"1261527110536978432"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/18ACB3976EFE748947527F99DFD35846\/S0007125000263745a.pdf\/reducing_antipsychotic_medication_in_people_with_a_learning_disability.pdf","method":"pii","verification":"lookup"},"timestamp":"2020-10-14T23:35:56Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2020-05-16T02:27:30Z","subj_id":"twitter:\/\/status?id=1261483383206510593","id":"40c7a62c-e410-4599-8bca-37a42f0da13a","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20200516-twitter-527e03e2-c9d5-482b-843b-4bb16701a7be","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1261483383206510593","url":"twitter:\/\/status?id=1261483383206510593","title":"Tweet 1261483383206510593","issued":"2020-05-16T02:27:30.000Z","author":{"url":"twitter:\/\/user?screen_name=kenichi_ohkubo"},"original-tweet-url":"twitter:\/\/status?id=1261483383206510593","original-tweet-author":null,"alternative-id":"1261483383206510593"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/18ACB3976EFE748947527F99DFD35846\/S0007125000263745a.pdf\/reducing_antipsychotic_medication_in_people_with_a_learning_disability.pdf","method":"pii","verification":"lookup"},"timestamp":"2020-10-14T23:36:22Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2020-05-16T02:38:29Z","subj_id":"twitter:\/\/status?id=1261486146124517378","id":"ac7e7d7d-5984-4dff-8d70-fe46bb3d508a","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20200516-twitter-72d2b27c-8e46-4048-bea6-6a7aab99e45f","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1261486146124517378","url":"twitter:\/\/status?id=1261486146124517378","title":"Tweet 1261486146124517378","issued":"2020-05-16T02:38:29.000Z","author":{"url":"twitter:\/\/user?screen_name=mitinokutaisyou"},"original-tweet-url":"twitter:\/\/status?id=1261483383206510593","original-tweet-author":"twitter:\/\/user?screen_name=kenichi_ohkubo","alternative-id":"1261486146124517378"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/18ACB3976EFE748947527F99DFD35846\/S0007125000263745a.pdf\/reducing_antipsychotic_medication_in_people_with_a_learning_disability.pdf","method":"pii","verification":"lookup"},"timestamp":"2020-10-14T23:36:53Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2020-05-16T17:00:54Z","subj_id":"twitter:\/\/status?id=1261703183350427649","id":"2fd195c3-7340-404f-b80e-50730f5b756f","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20200516-twitter-75295051-96d4-447f-8a06-7f420e17c1d6","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1261703183350427649","url":"twitter:\/\/status?id=1261703183350427649","title":"Tweet 1261703183350427649","issued":"2020-05-16T17:00:54.000Z","author":{"url":"twitter:\/\/user?screen_name=kinokuniyanet"},"original-tweet-url":"twitter:\/\/status?id=1261483383206510593","original-tweet-author":"twitter:\/\/user?screen_name=kenichi_ohkubo","alternative-id":"1261703183350427649"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/18ACB3976EFE748947527F99DFD35846\/S0007125000263745a.pdf\/reducing_antipsychotic_medication_in_people_with_a_learning_disability.pdf","method":"pii","verification":"lookup"},"timestamp":"2020-10-14T23:36:55Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2020-05-16T02:28:04Z","subj_id":"twitter:\/\/status?id=1261483524235788289","id":"f1ec3974-7d1c-43a8-95d3-d83c2325bc10","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20200516-twitter-fb033c07-79c4-4d26-ba98-a7fb52d2a60e","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1261483524235788289","url":"twitter:\/\/status?id=1261483524235788289","title":"Tweet 1261483524235788289","issued":"2020-05-16T02:28:04.000Z","author":{"url":"twitter:\/\/user?screen_name=king1234stone"},"original-tweet-url":"twitter:\/\/status?id=1261483383206510593","original-tweet-author":"twitter:\/\/user?screen_name=kenichi_ohkubo","alternative-id":"1261483524235788289"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/18ACB3976EFE748947527F99DFD35846\/S0007125000263745a.pdf\/reducing_antipsychotic_medication_in_people_with_a_learning_disability.pdf","method":"pii","verification":"lookup"},"timestamp":"2020-10-14T23:39:02Z","relation_type_id":"discusses"},{"license":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/","obj_id":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","source_token":"45a1ef76-4f43-4cdc-9ba8-5a6ad01cc231","occurred_at":"2020-05-17T07:45:32Z","subj_id":"twitter:\/\/status?id=1261925807401734144","id":"ea8724ae-e0a8-4439-8f4f-e7cc2d12d5d3","evidence_record":"https:\/\/evidence.eventdata.crossref.org\/evidence\/20200517-twitter-4f306018-012f-42b8-99b5-19fae9d40c31","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"pid":"twitter:\/\/status?id=1261925807401734144","url":"twitter:\/\/status?id=1261925807401734144","title":"Tweet 1261925807401734144","issued":"2020-05-17T07:45:32.000Z","author":{"url":"twitter:\/\/user?screen_name=21yuyue"},"original-tweet-url":"twitter:\/\/status?id=1261483383206510593","original-tweet-author":"twitter:\/\/user?screen_name=kenichi_ohkubo","alternative-id":"1261925807401734144"},"source_id":"twitter","obj":{"pid":"https:\/\/doi.org\/10.1192\/bjp.176.1.42","url":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/18ACB3976EFE748947527F99DFD35846\/S0007125000263745a.pdf\/reducing_antipsychotic_medication_in_people_with_a_learning_disability.pdf","method":"pii","verification":"lookup"},"timestamp":"2020-10-15T00:05:24Z","relation_type_id":"discusses"}]}}